Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.37 |
| ▸ | PRKCG | P05129 | 1/20 | 0.37 |
| ▸ | PRKCB | P05771 | 1/20 | 0.37 |
| ▸ | PRKCA | P17252 | 1/20 | 0.37 |
| ▸ | PRKCH | P24723 | 1/20 | 0.37 |
| ▸ | PRKCI | P41743 | 1/20 | 0.37 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.37 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.37 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.37 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.37 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.37 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27039032 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL6764178 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL27038952 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL27039098 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL7104064 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL5086553 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL25185980 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL9745732 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL199794 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 | |
| SCHEMBL7101548 | 1.00 | ACE2 (0.47) | ACE2LMNADNM1OPRM1PRKD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| US-20240024252-A1 | LIPID NANOPARTICLE | NITTO DENKO CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| WO-2024018762-A1 | PH-SENSITIVE CATIONIC LIPID AND LIPID NANOPARTICLE | 国立大学法人北海道大学 | 2024-01-25 | — | — | WO | disclosed |
| WO-2024018761-A1 | NEUTRAL LIPID AND LIPID NANOPARTICLE | 国立大学法人北海道大学 | 2024-01-25 | — | — | WO | disclosed |
| WO-2023191050-A1 | PHARMACEUTICAL COMPOSITION FOR DELIVERY TO CANCER, OR IMMUNOSTIMULATING COMPOSITION | 日東電工株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023188830-A1 | LIPID NANOPARTICLES | 国立大学法人北海道大学 | 2023-10-05 | — | — | WO | disclosed |
| EP-4223314-A1 | LIPID NANOPARTICLE | National University Corporation Hokkaido University (JP) | 2023-08-09 | — | — | EP | disclosed |
| CN-116367718-A | Lipid nanoparticles | 国立大学法人北海道大学 | 2023-06-30 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| EP-3039055-B1 | ALIPHATIC POLYCARBONATE-BASED SURFACE ACTIVE AGENTS | SASOL CHEMICALS USA LLC (US) | 2020-04-15 | — | — | EP | disclosed |
| CN-105814112-B | Surfactant based on aliphatic polycarbonate | 萨索尔化学品(美国)有限责任公司 | 2019-03-08 | — | — | CN | disclosed |
| US-10011758-B2 | Aliphatic polycarbonate-based surface active agents | SASOL CHEMICALS (USA) LLC (US) | 2018-07-03 | — | — | US | disclosed |
| US-20160200962-A1 | Aliphatic Polycarbonate-Based Surface Active Agents | SASOL CHEMICALS (USA) LLC | 2016-07-14 | — | — | US | disclosed |
| EP-3039055-A1 | ALIPHATIC POLYCARBONATE-BASED SURFACE ACTIVE AGENTS | Sasol Chemicals (USA) LLC (US) | 2016-07-06 | — | — | EP | disclosed |
| WO-2015031348-A1 | ALIPHATIC POLYCARBONATE-BASED SURFACE ACTIVE AGENTS | SASOL CHEMICALS (USA) LLC (US) | 2015-03-05 | — | — | WO | disclosed |
| EP-0206037-B1 | CARBAMATES AND UREAS OF N-(2-AMINOACYLAMIDO-2-DESOXY-HEXOSYL) AMIDE, METHOD FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE | BAYER AG (DE) | 1992-01-15 | — | — | EP | disclosed |
| US-4855283-A | IMMUNE SYSTEM STIMULANTS | BAYER AKTIENGESELLSCHAFT (DE) | 1989-08-08 | — | — | US | disclosed |
| CN-86104185-A | The preparation technology and the medicinal use thereof of N-(2-aminoacyl amino-2-deoxidation-hexose-based)-amides, amino formate and a ureas | — | 1987-04-08 | — | — | CN | disclosed |
| EP-0206037-A2 | Carbamates and ureas of N-(2-aminoacylamido-2-desoxy-hexosyl) amide, method for their preparation and their pharmaceutical use | BAYER AG (DE) | 1986-12-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240024252-A1 | LIPID NANOPARTICLE | LIPC, ACOX1, ABCB4 | ACE2 2922/4885LMNA 1094/4885DNM1 2497/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.